跳至主要内容
临床试验/CTRI/2026/02/104976
CTRI/2026/02/104976尚未招募不适用

A descriptive study to assess the symptom burden in cancer patients undergoing treatment in GGSMCH, Faridkot, Punjab.

Arshleen Kaur1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2026年3月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
130
试验地点
1

研究概览

简要总结

This study aims to assess the symptom burden among cancer patients undergoing treatment at Guru Gobind Singh Medical College & Hospital Punjab. Cancer remains a leading global health concern, as reported by the World Health Organization, with high incidence and mortality rates. Patients undergoing cancer treatment frequently experience multiple physical and psychological symptoms such as pain, fatigue, nausea, anxiety, and sleep disturbances, which collectively contribute to significant symptom burden and reduced quality of life.

A quantitative descriptive cross-sectional design will be used, enrolling 130 adult cancer patients selected through convenient sampling. Data will be collected using a self-developed socio-demographic and clinical profile sheet and the standardized Rotterdam Symptom Checklist (RSCL). The study seeks to evaluate the level of symptom burden and examine its association with selected sociodemographic and clinical variables. Findings are expected to support systematic symptom assessment, improve supportive care strategies, and enhance overall patient well-being and quality of life.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • • Adult patients above 18 years diagnosed with cancer.
  • • Patients undergoing treatment in GGSMCH, Faridkot • Patients available at the time of data collection.

排除标准

  • • Patients who are not willing to participate.
  • • Patients who are not able to respond due to severe illness.

研究者

发起方
Arshleen Kaur
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Arshleen Kaur

University College of Nursing, Faridkot

研究点 (1)

Loading locations...

相似试验